These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Application of a new radioligand F-18 FET, and its clinical benefit in the diagnosis of primary and secondary brain tumors Új radioligand, a 18F-FET alkalmazása, klinikai haszna a primer és szekund...